CRISPR Therapeutics AG

SecurityCRSP / CRISPR Therapeutics AG
InstitutionSei Investments Co
Latest Disclosed Ownership12,658 shares
Latest Disclosed Value $ 663,577
Sei Investments Co reports 4.25% increase in ownership of CRSP / CRISPR Therapeutics AG

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 12,658 shares of CRISPR Therapeutics AG (US:CRSP) valued at $663,786 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 12,142 shares of CRISPR Therapeutics AG. This represents a change in shares of 4.25% during the quarter. The current value of the position is $656,191 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 12,658 516 4.25 664 -15.65 0.0007
2025-11-13 2025-09-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 12,142 728 6.38 787 41.62 0.0008
2025-08-14 2025-06-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 11,414 11,414 555 0.0006
2024-02-14 2023-12-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 0 -55,455 -100.00 0 -100.00
2023-11-14 2023-09-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 55,455 -2,414 -4.17 2,517 -22.51 0.0045
2023-08-11 2023-06-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 57,869 -6,764 -10.47 3,249 11.12 0.0057
2023-05-12 2023-03-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 64,633 64,633 2,923 0.0054
2023-02-10 2022-12-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 0 -54,179 -100.00 0 -100.00
2022-11-14 2022-09-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 54,179 2,494 4.83 3,540 12.74 0.0079
2022-08-15 2022-06-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 51,685 51,685 3,140 0.0068
2022-05-13 2022-03-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 0 -3,240 -100.00 0 -100.00
2022-02-14 2021-12-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 3,240 -576 -15.09 247 -42.15 0.0005
2021-11-12 2021-09-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 3,816 642 20.23 427 -16.93 0.0009
2021-08-06 2021-06-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 3,174 817 34.66 514 79.09 0.0011
2021-05-12 2021-03-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 2,357 256 12.18 287 -10.87 0.0007
2021-02-08 2020-12-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 2,101 2,101 322 0.0008
2018-11-08 2018-09-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 0 -800 -100.00 0 -100.00
2018-08-03 2018-06-30 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 800 0 0.00 47 27.03 0.0002
2018-05-11 2018-03-31 13F CRISPR THERAPEUTICS NAMEN AKT H17182108 800 800 37 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.